SBI actively sources and applies for new streams of funding within its research brief. We aim not only to realise the development of concepts, but to actively promote translation and application through collaborations with industry and other partners.
In order to do this, SBI will create a network of researchers locally that will work with a new network of academic partners and industries globally to deliver value for Ireland and Europe.
DevelopMed, a Marie Skłodowska-Curie (MSCA) COFUND Action, is a new International Training and Career Development Fellowship Programme coordinated by Systems Biology Ireland.
The EU-funded CLARIFY project will identify the risk factors that impact cancer patient´s quality of life after oncological treatment by using Big Data and AI. Data from more than 15,000 survivors from breast, lung and lymphoma cancer (the most prevalent types) will be analyzed for this purpose.
A Pioneering Analysis Platform Funded By Science Foundation Ireland (SFI) Providing Metabolomic, Proteomic, and Chemical Analysis.
Precision Oncology Ireland (POI) is a consortium of five Irish universities, six Irish cancer research charities, and 10 companies aiming to develop new diagnostics and therapeutics for the personalised treatment of cancer.
The International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches - SPRINT is a COST (Cooperation in Science and Technology) project that allows excellent researchers and clinicians in the field of innovation to cooperate and jointly develop their ideas in scientific and technology sectors.
3TR: Largest-ever Innovative Medicine Initiative 2 (IMI2) immunology project to improve disease management of non-responders to therapy across seven immune-mediated diseases
Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based stratification solutions.
The European Nanotechnology Community Informatics Platform: Bridging data and disciplinary gaps for industry and regulators.
Fellowship Programme supporting Career Development and Interdisciplinary Training in Omics driven Personalised Medicine.
Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine
Systems-based view of melanoma progression: towards novel diagnostic (and therapeutic) applications